Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-24

Clinical Trial Update: Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effect of abobotulinumtoxinA in the gastrocnemius to improve equinus and plantar fasciitis pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AbobotulinumtoxinA (abobotulinumtoxinA)

Snippet

Sponsor: University Foot and Ankle Foundation | Conditions: Plantar Fasciitis, Plantar Fasciitis, Chronic | Phase 2 | Status: UNKNOWN